Literature DB >> 24337239

[Cutaneous leishmaniasis. Diagnosis and therapy in northern Afghanistan].

R Dieterle1, H Pillekamp.   

Abstract

BACKGROUND: The German S1 guidelines from 2009 contain a variety of recommendations for the treatment of cutaneous leishmaniasis. PATIENTS AND METHODS: We report the results of our diagnostic procedures and treatment of 32 international patients in autumn 2010 in northern Afghanistan.
RESULTS: Giemsa stain confirmed the clinical diagnosis within 24 hours. Eleven simple lesions and one larger ulcer responded well to cryotherapy and intralesional sodium stibogluconate. More complex lesions in 19 patients responded well to oral miltefosine. One patient refused outpatient therapy.
CONCLUSIONS: Cryotherapy and intralesional antimony compounds showed good results in early lesions of cutaneous leishmaniasis in northern Afghanistan. Outpatient treatment of complex lesions with miltefosine was successful in all cases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24337239     DOI: 10.1007/s00105-013-2725-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?

Authors:  Gloria Morizot; Pascal Delgiudice; Eric Caumes; Emmanuel Laffitte; Pierre Marty; Alain Dupuy; Claudine Sarfati; Smain Hadj-Rabia; Herve Darie; Anne-Sophie LE Guern; Afif Ben Salah; Francine Pratlong; Jean-Pierre Dedet; Max Grögl; Pierre A Buffet
Journal:  Am J Trop Med Hyg       Date:  2007-01       Impact factor: 2.345

Review 2.  [Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy].

Authors:  E von Stebut; U Schleicher; C Bogdan
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

3.  Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.

Authors:  Anette Chrusciak-Talhari; Reynaldo Dietze; Carolina Chrusciak Talhari; Roberto Moreira da Silva; Ellen Priscila Gadelha Yamashita; Gerson de Oliveira Penna; Paulo Roberto Lima Machado; Sinésio Talhari
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

4.  Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.

Authors:  Abdulrahman A Alrajhi; Elfaki A Ibrahim; Edward B De Vol; Mohammad Khairat; Rajab M Faris; James H Maguire
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

5.  Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.

Authors:  P P A M van Thiel; T Leenstra; P A Kager; H J de Vries; M van Vugt; W F van der Meide; A Bart; J E Zeegelaar; A van der Sluis; H D F H Schallig; T van Gool; W R Faber; P J de Vries
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

6.  Factors associated with the use of protective measures against vector-borne diseases among troops deployed to Iraq and Afghanistan.

Authors:  John P Vickery; David R Tribble; Shannon D Putnam; Timothy McGraw; John W Sanders; Adam W Armstrong; Mark S Riddle
Journal:  Mil Med       Date:  2008-11       Impact factor: 1.437

7.  Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan.

Authors:  Michael Faulde; Joachim Schrader; Gerhard Heyl; Mohammed Amirih
Journal:  Acta Trop       Date:  2007-11-09       Impact factor: 3.112

8.  Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

Authors:  Paulo R Machado; Julia Ampuero; Luiz H Guimarães; Leonardo Villasboas; Ana T Rocha; Albert Schriefer; Rosana S Sousa; Anette Talhari; Gerson Penna; Edgar M Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

9.  Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan.

Authors:  Marie Plourde; Adriano Coelho; Yoav Keynan; Oscar E Larios; Momar Ndao; Annie Ruest; Gaétan Roy; Ethan Rubinstein; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

10.  Zoonotic cutaneous leishmaniasis, Afghanistan.

Authors:  Michael K Faulde; Gerhard Heyl; Mohammed L Amirih
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

View more
  2 in total

Review 1.  [Epidemiology and prevention of leishmaniasis in northern Afghanistan].

Authors:  M K Faulde; K Erkens; R Dieterle
Journal:  Hautarzt       Date:  2015-05       Impact factor: 0.751

2.  Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.

Authors:  Rosiana Estéfane da Silva; Janaína de Pina Carvalho; Dario Brock Ramalho; Maria Camilo Ribeiro De Senna; Hugo Silva Assis Moreira; Ana Rabello; Erika Cota; Gláucia Cota
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02       Impact factor: 2.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.